VAMG
PFE icon

Voisard Asset Management Group’s Pfizer PFE Stock Holding History

Voisard Asset Management Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,675
Closed -$77.4K – 497
2024
Q3 		$77.4K Sell
2,675
-292
-10% -$8.52K 0.03% 150
2024
Q2 		$83K Sell
2,967
-70
-2% -$1.93K 0.04% 119
2024
Q1 		$84.3K Buy
3,037
+39
+1% +$1.08K 0.05% 103
2023
Q4 		$86.3K Buy
+2,998
New +$90.6K 0.05% 102

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Voisard Asset Management Group's PFE Position: Q4 2024 in Review

Voisard Asset Management Group sold out of Pfizer (PFE) in Q4 2024, closing a stake of 2,675 shares — an estimated $77.4K sold.

Voisard Asset Management Group first reported a position in PFE in Q4 2023 and held it in 4 quarters. The position peaked at $86.3K in Q4 2023. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Voisard Asset Management Group reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Voisard Asset Management Group sold 2,675 Pfizer shares in Q4 2024, an estimated $77.4K.
  • Voisard Asset Management Group first reported a position in Pfizer in Q4 2023 and held it in 4 quarters.
  • Voisard Asset Management Group's Pfizer position peaked at $86.3K in Q4 2023.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Voisard Asset Management Group's 13F filing for Q4 2024, filed 7 Feb 2025.